Professor, Medicine, UCSD School of Medicine
Allergy & Immunology
Dr. Arthur Kavanaugh, MD
|
|
Give Review
Dr. Arthur Kavanaugh practices Allergy & Immunology. He went to Saint Louis University School of Medicine. Saint Louis University School of Medicine is ranked 67 in research and 57 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification", "Fellow (FACR)" and "Fellow (FAAAAI)". Doctor Arthur Kavanaugh, MD has written publications. He has 45 publications published with PubMed. The lastest paper is: 'Novel approaches to biological therapy for psoriatic arthritis.' Dr. Arthur Kavanaugh accepts Medicare.
Publications
- Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Axial SpondyloArthritis Pat...
- Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthri...
- Incidence and Predictors of Biological Antirheumatic Drug Discontinuation Attempts among Patients with Rheumatoid Arthritis in Remission: A CORRONA and NinJa Collabora...
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.
- Novel approaches to biological therapy for psoriatic Arthritis.
- Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis.
- Patients with psoriatic Arthritis who achieve minimal disease activity in response to golimumab therapy demonstrate less radiographic progression: Results through 5 ye...
- Discontinuation of tumour necrosis factor inhibitors in patients with rheumatoid Arthritis in low-disease activity: persistent benefits. Data from the Corrona registry.
- The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid Arthritis.
- Proceedings from the ACR Reproductive Health Summit: The management of fertility, pregnancy and lactation in women with autoimmune and systemic inflammatory Diseases.
- Systematic Review of Treatments for Psoriatic Arthritis: 2014 Update for the GRAPPA.
- Effects of fostamatinib, an oral spleen tyrosine kinase inhibitor, in rheumatoid Arthritis patients with an inadequate response to methotrexate: Results from a phase I...
- A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of 2 Dosing Regimens of Fostamatinib in Patients with Rheumatoid Arthritis...
- Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid Arthritis?
- Improvements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of p...
- GRAPPA Treatment Recommendations: An Update from the GRAPPA 2013 Annual Meeting.
- Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic Arthritis: results from a lon...
- Treatment of psoriatic Arthritis in a phase 3 randomised, placebo-controlled trial with apremilast, an oral phosphodiesterase 4 inhibitor.
- Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic Arthritis: results of an integrated analysis...
- Adjustment of therapy in rheumatoid Arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the r...
- Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic Arthritis despite conventional non-biological and biol...
- Longterm Effect of Delaying Combination Therapy with Tumor Necrosis Factor Inhibitor in Patients with Aggressive Early Rheumatoid Arthritis: 10-year Efficacy and Safet...
- Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease.
- Psoriatic Arthritis: current therapy and future directions.
- Utility of the ultrasound examination of the hand and wrist joints in the management of established rheumatoid Arthritis.
- Adverse effects of golimumab in the treatment of rheumatologic Diseases.
- Clinical, Functional, and Radiographic Benefits of Longterm Adalimumab Plus Methotrexate: Final 10-year Data in Longstanding Rheumatoid Arthritis.
- The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or Ankylosing spondylitis.
- Ustekinumab improves Arthritis-related and skin-related quality of life in patients with active psoriatic Arthritis: patient reported outcomes from randomized and doub...
- Improvements in productivity at paid work and within household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patie...
- Treatment of spondyloarthropathy: the potential for agents other than TNF inhibitors.
- Patient reported outcomes and the association with clinical response in patients with active psoriatic Arthritis treated with golimumab: Findings through 2 years of th...
- Documentation of off-label use of biologics in Rheumatoid Arthritis.
- Effects of Fostamatinib (R788), an Oral Spleen Tyrosine Kinase Inhibitor, on Health-related Quality of Life in Patients with Active Rheumatoid Arthritis: Analyses of P...
- Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic Arthritis patients treated with golimumab.
- Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic Arthritis: results from a long-term extens...
- Golimumab in psoriatic Arthritis: One-year clinical efficacy, radiographic, and safety results from a phase III, randomized, placebo-controlled trial.
- Assessment of psoriatic nail Disease activity by rheumatologists: Comment on the article by Lubrano et al.
- Treatment of Psoriatic Arthritis with Tumor Necrosis Factor Inhibitors: Longer-term Outcomes Including Enthesitis and Dactylitis with Golimumab Treatment in the Longte...
- Use of the 28-Joint Count Yields Significantly Higher Concordance Between Different Examiners Than the 66/68-Joint Count.
- Clinical, functional and radiographic consequences of achieving stable low Disease activity and remission with adalimumab plus methotrexate or methotrexate alone in ea...
- Patient-reported outcomes in rheumatoid Arthritis.
- Perceptions of Disease and health-related quality of life among patients with gout.
- Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic Arthritis: Twenty-four-week efficac...
Schools
Saint Louis University School Of Medicine
Baylor College Of Med
Southwestern University
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Non-Spinal Nerve Blocks
Conditions Treated
- Acute Pharyngitis
- Acute Sinusitis
- Allergic Rhinitis
- Ankylosing Spondylitis
- View All
Doctors Specialties
- Rheumatology
- Allergy
- Immunology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACR)
- Fellow (FAAAAI)
Education
-
Baylor College of Medicine -
Saint Louis University School of Medicine
Hospital
-
UC San Diego Health
Drug Facts
| NPI NUMBER | 1679584486 | |
| NPPES Provider LastName | KAVANAUGH | |
| NPPES Provider FirstName | ARTHUR | |
| NPPES Provider ZIPCode | 920371300 | |
| NPPES Provider State | CA | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 582.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 26.0 | |
| Percent Opioid Claims | 4.47 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1679584486 |
| Last Name Of The Provider | KAVANAUGH |
| First Name Of The Provider | ARTHUR |
| View All |
Similar Doctors
|
|
Dr. Jafar F. Farnam, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David H. Broide, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ronald A. Simon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Taylor A. Doherty, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alexa P. Kollmeier, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephen I. Wasserman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David A. Mathison, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vaani Jegapragasan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ken D. Pischel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter J. Weis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zuhre N. Tutuncu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neda Yazdi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin Y. Tse, MD |
|
|
Dr. Janet M. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hyman Arthur Silverman, MD
This Doctor is OpenDoctor Recommended.
|